Speaker Profile

Ph.D., Chief Executive, Healx Ltd

Tim is a tech entrepreneur from the Cambridge Cluster (UK). He is passionate about the application of artificial intelligence for drug discovery. He is the co-founder and Chief Executive of Healx Ltd, a tech company focused on accelerating treatments for rare diseases. Passionate about patient impact, he is also the Founding Director of the Cambridge Rare Disease Network. He obtained his PhD from Cambridge University in Biophysical Neuroscience and his MEng in Biochemical-Engineering from Brussels University.

AI and Data Sciences Showcase: Healx
Healx identifies existing drugs that could treat rare diseases, offering a cost effective way to improve patient quality of life.

Translating 100 Rare Disease Treatments By 2025
From the 7,000 rare diseases, 95% are without approved treatment. Affecting 350M people world-wide. To address this huge therapeutic unmet need, Healnet was developed. The world’s leading AI-platform for rare diseases, enabling large-scale and hypothesis-free drug discovery.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.